2015
DOI: 10.1038/srep10934
|View full text |Cite
|
Sign up to set email alerts
|

Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of AMPA receptor in the hippocampus

Abstract: The acute neurotoxicity of oligomeric forms of amyloid-β 1-42 (Aβ) is implicated in the pathogenesis of Alzheimer’s disease (AD). However, how these oligomers might first impair neuronal function at the onset of pathology is poorly understood. Here we have examined the underlying toxic effects caused by an increase in levels of intracellular Aβ, an event that could be important during the early stages of the disease. We show that oligomerised Aβ induces a rapid enhancement of AMPA receptor-mediated synaptic tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
78
2

Year Published

2016
2016
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 89 publications
(82 citation statements)
references
References 73 publications
2
78
2
Order By: Relevance
“…There is a growing body of evidence implicating CP-AMPARs during the onset of synaptic pathology in neurological disorders [21, 35, 47, 60]. Previous analyses of hippocampal postsynaptic density fractions from human AD patients showed an increase in GluA1 levels compared to healthy controls, whereas no changes in NMDAR subunit expression were observed [41], suggesting a selective increase in GluA1-containing receptors in the hippocampus of AD patients.…”
Section: Discussionmentioning
confidence: 99%
“…There is a growing body of evidence implicating CP-AMPARs during the onset of synaptic pathology in neurological disorders [21, 35, 47, 60]. Previous analyses of hippocampal postsynaptic density fractions from human AD patients showed an increase in GluA1 levels compared to healthy controls, whereas no changes in NMDAR subunit expression were observed [41], suggesting a selective increase in GluA1-containing receptors in the hippocampus of AD patients.…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, intracellular application of oligomerised Aβ causes an acute increase in AMPAR-mediated synaptic responses, which requires PKA phosphorylation of S845 in GluA1. Ablation of GluA1, but not GluA2, prevents this increase, consistent with intracellular Aβ causing an enhancement of synaptic CP-AMPAR number and consequent excitotoxicity 146 . The selective loss of GluA2-containing AMPARs and the subsequent increase in intracellular Ca 2+ due to the expression of CP-AMPARs is implicated in the pathology of many other diseases.…”
Section: Ampar Subunits and Diseasementioning
confidence: 74%
“…They are tetramers, often heterotetramers, made up of four subunits, called GluR1–4 or GluA1–4 [45]. GluR1 and GluR2 are vital in the normal functioning of the human brain, and also have roles in neurological diseases, such as Alzheimer’s disease [46,47] and drug addiction [48,49]. Evidence for AMPA receptor expression in iNGN synapses was confirmed by the kinetic properties of mEPSCs (Fig 6 and Table 1), inhibitor studies (Fig 7), and by immunocytochemistry using antibodies against GluR1 and GluR2 (S4 Fig and S5 Fig).…”
Section: Discussionmentioning
confidence: 99%